Third Blog Post In Series Examines China’s History Of Artemisinin Drug Development
Council on Foreign Relation’s “Asia Unbound”: Artemisinin’s Rocky Road to Globalization: Part III
In part three of his series on anti-malarial artemisinin drugs, Yanzhong Huang, CFR senior fellow for global health, explores China’s efforts to increase its market share of artemisinin-based combination therapies worldwide. “…To sum up, China has come a long way in developing and promoting its own artemisinin-based products, but there is still a long way to go before it is able to seriously challenge the status quo in the international anti-malarial market” (3/11).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.